| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Li Guan | |
| Qing Tian | |||
| Ying Xiang | |||
| Shuai-Shuai Niu | |||
| P2860 | cites work | Notch signaling induces cell cycle arrest in small cell lung cancer cells | Q24291129 |
| New microRNAs from mouse and human | Q24540176 | ||
| The Hippo Signaling Pathway in Development and Cancer | Q24603986 | ||
| Global cancer statistics, 2012 | Q27860501 | ||
| A dual yet opposite growth-regulating function of miR-204 and its target XRN1 in prostate adenocarcinoma cells and neuroendocrine-like prostate cancer cells | Q28573536 | ||
| Target mRNA abundance dilutes microRNA and siRNA activity | Q28914780 | ||
| A microRNA miR-34a-regulated bimodal switch targets Notch in colon cancer stem cells. | Q30539598 | ||
| HMGN5/NSBP1: a new member of the HMGN protein family that affects chromatin structure and function | Q33637905 | ||
| EMT and MET: necessary or permissive for metastasis? | Q33869775 | ||
| Definition of microRNAs that repress expression of the tumor suppressor gene FOXO1 in endometrial cancer | Q33894047 | ||
| Down-regulation of tumor suppressor A kinase anchor protein 12 in human hepatocarcinogenesis by epigenetic mechanisms | Q34146004 | ||
| MicroRNA-494 targeting both proapoptotic and antiapoptotic proteins protects against ischemia/reperfusion-induced cardiac injury | Q34207303 | ||
| TWIST and ovarian cancer stem cells: implications for chemoresistance and metastasis | Q34365639 | ||
| CRNDE affects the malignant biological characteristics of human glioma stem cells by negatively regulating miR-186. | Q34487797 | ||
| Polymorphisms in microRNA targets: a gold mine for molecular epidemiology | Q34778438 | ||
| MicroRNAs miR-186 and miR-150 down-regulate expression of the pro-apoptotic purinergic P2X7 receptor by activation of instability sites at the 3'-untranslated region of the gene that decrease steady-state levels of the transcript | Q34804590 | ||
| Genetic polymorphisms in miRNAs targeting the estrogen receptor and their effect on breast cancer risk. | Q34879842 | ||
| miR-186 and 326 predict the prognosis of pancreatic ductal adenocarcinoma and affect the proliferation and migration of cancer cells | Q35151728 | ||
| Increased Expression of GOLPH3 is Associated with the Proliferation of Prostate Cancer | Q35349161 | ||
| Expression and promotor hypermethylation of miR-34a in the various histological subtypes of ovarian cancer. | Q35924210 | ||
| Intron Retention and TE Exonization Events in ZRANB2. | Q36063492 | ||
| Induction of miRNA-181a by genotoxic treatments promotes chemotherapeutic resistance and metastasis in breast cancer | Q36338901 | ||
| MicroRNA-186 induces sensitivity of ovarian cancer cells to paclitaxel and cisplatin by targeting ABCB1 | Q36341067 | ||
| miR-186 inhibits cell proliferation of prostate cancer by targeting GOLPH3 | Q37215525 | ||
| miR-186 affects the proliferation, invasion and migration of human gastric cancer by inhibition of Twist1. | Q37694872 | ||
| Milk and dairy consumption and risk of bladder cancer: a meta-analysis | Q37964263 | ||
| Regulation of miR-23b expression and its dual role on ROS production and tumour development. | Q38206343 | ||
| A catalog of polymorphisms falling in microRNA-binding regions of cancer genes | Q38297295 | ||
| PTEN and PI3K/AKT in non-small-cell lung cancer. | Q38629644 | ||
| miRNA-186 inhibits prostate cancer cell proliferation and tumor growth by targeting YY1 and CDK6. | Q38701099 | ||
| MicroRNA-186-5p overexpression modulates colon cancer growth by repressing the expression of the FAM134B tumour inhibitor. | Q38702143 | ||
| Cell-Cycle-Targeting MicroRNAs as Therapeutic Tools against Refractory Cancers. | Q38708075 | ||
| MiR-186 Inhibited Migration of NSCLC via Targeting cdc42 and Effecting EMT Process | Q38711597 | ||
| TUG1 mediates methotrexate resistance in colorectal cancer via miR-186/CPEB2 axis | Q38711940 | ||
| The long noncoding RNA PVT1 functions as a competing endogenous RNA by sponging miR-186 in gastric cancer | Q38719489 | ||
| PVT1 affects growth of glioma microvascular endothelial cells by negatively regulating miR-186. | Q38738395 | ||
| miR-186 regulates chemo-sensitivity to paclitaxel via targeting MAPT in non-small cell lung cancer (NSCLC). | Q38740398 | ||
| MicroRNA-186 suppresses cell proliferation and metastasis through targeting MAP3K2 in non-small cell lung cancer | Q38753282 | ||
| microRNA-186 Suppresses Cell Proliferation and Metastasis Through Targeting Sentrin Specific Protease 1 in Renal Cell Carcinoma | Q38760455 | ||
| microRNA-186 inhibits cell proliferation and induces apoptosis in human esophageal squamous cell carcinoma by targeting SKP2. | Q38819565 | ||
| miR-186 downregulates protein phosphatase PPM1B in bladder cancer and mediates G1-S phase transition | Q38825749 | ||
| miR-186 regulation of Twist1 and ovarian cancer sensitivity to cisplatin | Q38888166 | ||
| miR-186 downregulation correlates with poor survival in lung adenocarcinoma, where it interferes with cell-cycle regulation. | Q38928705 | ||
| miR-124 inhibits growth and invasion of gastric cancer by targeting ROCK1. | Q38961961 | ||
| MiR-186 targets ROCK1 to suppress the growth and metastasis of NSCLC cells | Q38988557 | ||
| miR-186 inhibits muscle cell differentiation through myogenin regulation | Q39037772 | ||
| NR5A2 discovering compounds that block tumor growth in PDAC. | Q39264548 | ||
| MicroRNA-186 targets Yes-associated protein 1 to inhibit Hippo signaling and tumorigenesis in hepatocellular carcinoma | Q39654967 | ||
| MiR-186 suppresses the growth and metastasis of bladder cancer by targeting NSBP1. | Q40625331 | ||
| MicroRNA-186 regulates the invasion and metastasis of bladder cancer via vascular endothelial growth factor C. | Q41665099 | ||
| MicroRNA-186 affects the proliferation of tumor cells via yes-associated protein 1 in the occurrence and development of pancreatic cancer | Q41672310 | ||
| MicroRNA-186 suppresses lung cancer progression by targeting SIRT6. | Q47361771 | ||
| The Dual Regulatory Role of MiR-181a in Breast Cancer | Q47412689 | ||
| The long noncoding RNA HULC promotes liver cancer by increasing the expression of the HMGA2 oncogene via sequestration of the microRNA-186. | Q48002616 | ||
| Suppression of Disheveled-Axin Domain Containing 1 (DIXDC1) by MicroRNA-186 Inhibits the Proliferation and Invasion of Retinoblastoma Cells. | Q48372498 | ||
| Long noncoding RNA PVT1 promotes EMT via mediating microRNA-186 targeting of Twist1 in prostate cancer | Q49923086 | ||
| Arresting of miR-186 and releasing of H19 by DDX43 facilitate tumorigenesis and CML progression | Q49957676 | ||
| MiR-186 inhibits proliferation, migration, and invasion of non-small cell lung cancer cells by downregulating Yin Yang 1. | Q50071627 | ||
| MiR-186-5p upregulation inhibits proliferation, metastasis and epithelial-to-mesenchymal transition of colorectal cancer cell by targeting ZEB1. | Q50080442 | ||
| MicroRNA-186 serves as a tumor suppressor in oral squamous cell carcinoma by negatively regulating the protein tyrosine phosphatase SHP2 expression | Q50174418 | ||
| Long non-coding RNA PVT1 serves as a competing endogenous RNA for miR-186-5p to promote the tumorigenesis and metastasis of hepatocellular carcinoma. | Q50919252 | ||
| LncRNA HCP5 promotes follicular thyroid carcinoma progression via miRNAs sponge. | Q52363986 | ||
| Micro-RNA-186-5p inhibition attenuates proliferation, anchorage independent growth and invasion in metastatic prostate cancer cells. | Q52719567 | ||
| The function role of miR-181a in chemosensitivity to adriamycin by targeting Bcl-2 in low-invasive breast cancer cells. | Q53245125 | ||
| An interplay of miRNA abundance and target site architecture determines miRNA activity and specificity. | Q55374415 | ||
| Colorectal cancer: genetic abnormalities, tumor progression, tumor heterogeneity, clonal evolution and tumor-initiating cells. | Q55411157 | ||
| miR-186 promotes tumor growth in cutaneous squamous cell carcinoma by inhibiting apoptotic protease activating factor-1 | Q57787025 | ||
| miR-186 reverses cisplatin resistance and inhibits the formation of the glioblastoma-initiating cell phenotype by degrading Yin Yang 1 in glioblastoma | Q58597095 | ||
| TBL1XR1 promotes migration and invasion in osteosarcoma cells and is negatively regulated by miR-186-5p | Q60921924 | ||
| A Systematic Review of miR-29 in Cancer | Q61811185 | ||
| HOXD-AS1 promotes the epithelial to mesenchymal transition of ovarian cancer cells by regulating miR-186-5p and PIK3R3 | Q64079815 | ||
| MicroRNA-186 targets SKP2 to induce p27-mediated pituitary tumor cell cycle deregulation and modulate cell proliferation | Q64094803 | ||
| MicroRNA-186 promotes cell proliferation and inhibits cell apoptosis in cutaneous squamous cell carcinoma by targeting RETREG1 | Q64233448 | ||
| miR-186 inhibits cell proliferation in multiple myeloma by repressing Jagged1 | Q86931825 | ||
| Dual Functional MicroRNA-186-5p Targets both FGF2 and RelA to Suppress Tumorigenesis of Glioblastoma Multiforme | Q89305390 | ||
| Overview upon miR-21 in lung cancer: focus on NSCLC | Q90376926 | ||
| miR-186 inhibits proliferation, migration, and epithelial-mesenchymal transition in breast cancer cells by targeting Twist1 | Q90534527 | ||
| LncRNA SNHG16 Promotes Hepatocellular Carcinoma Proliferation, Migration and Invasion by Regulating miR-186 Expression | Q91783143 | ||
| miR-186 Suppresses the Progression of Cholangiocarcinoma Cells Through Inhibition of Twist1 | Q91894241 | ||
| miR-186 modulates hepatocellular carcinoma cell proliferation and mobility via targeting MCRS1-mediated Wnt/β-catenin signaling | Q92368136 | ||
| miR-186-5p Functions as a Tumor Suppressor in Human Osteosarcoma by Targeting FOXK1 | Q92527980 | ||
| Lycorine inhibited the cell growth of non-small cell lung cancer by modulating the miR-186/CDK1 axis | Q92605329 | ||
| EGFR, but not COX-2, protein in resected pancreatic ductal adenocarcinoma is associated with poor survival | Q92669175 | ||
| Long Intergenic Non-Protein Coding RNA 665 Regulates Viability, Apoptosis, and Autophagy via the MiR-186-5p/MAP4K3 Axis in Hepatocellular Carcinoma | Q92748612 | ||
| CircRNA circPDSS1 promotes the gastric cancer progression by sponging miR-186-5p and modulating NEK2 | Q92995882 | ||
| miR-186-5p promotes cell growth, migration and invasion of lung adenocarcinoma by targeting PTEN | Q93075512 | ||
| Overexpression of microRNA-186 inhibits angiogenesis in retinoblastoma via the Hedgehog signaling pathway by targeting ATAD2 | Q93145597 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P304 | page(s) | 233 | |
| P577 | publication date | 2020-03-05 | |
| P1433 | published in | Frontiers in Oncology | Q26839986 |
| P1476 | title | The Dual Role of miR-186 in Cancers: Oncomir Battling With Tumor Suppressor miRNA | |
| P478 | volume | 10 |
Search more.